Abemaciclib Metabolites M2 (Synonyms: LSN2839567) |
| Catalog No.GC35218 |
Abemaciclib Metabolites M2 (LSN2839567) est un métabolite de l'abemaciclib, agit comme un puissant inhibiteur de CDK4 et CDK6, avec des IC50 de 1,2 et 1,3 nM, respectivement. Activité anticancéreuse.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1231930-57-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Abemaciclib Metabolites M2 is a metabolite of abemaciclib, acts as a potent CDK4 and CDK6 inhibitor, with IC50s in the range of 1-3 nM. Anti-cancer activity[1]. CDK4|1-3 nM (IC50)|CDK6|1-3 nM (IC50)
[1]. Teresa Burke, et al. Abstract 2830: The major human metabolites of abemaciclib are inhibitors of CDK4 and CDK6. Cancer Research. July 2016, 76 (14).
Average Rating: 5 (Based on Reviews and 3 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *